Irritable bowel syndrome

Irritable bowel syndrome, or IBS, is a chronic functional gastrointestinal disorder. It is defined by a group of symptoms that affect the digestive system over a long period. These symptoms often include abdominal pain, bloating, and changes in bowel movement consistency. For many people, these symptoms can last for several years. While IBS does not affect life expectancy or lead to other serious diseases, it can significantly impact a person's quality of life. It may cause people to miss school or work due to frequent discomfort.

Researchers believe the condition involves a complex breakdown in the gut-brain axis. This is the communication system between the central nervous system and the digestive tract. When this axis is disrupted, the body may experience altered gut motility, which is the movement of food through the intestines. Many patients also suffer from visceral hypersensitivity, meaning they feel pain more intensely in their gut. Other proposed causes include genetic factors, neurotransmitter imbalances, and food sensitivities. Some people also experience small intestinal bacterial overgrowth, or SIBO, which is an excess of bacteria in the small intestine.

IBS can manifest in different ways depending on how the gut behaves. One common type is diarrhea-predominant IBS, where patients experience frequent loose stools. Another type is constipation-predominant IBS, where bowel movements are infrequent or difficult. Some people may experience a mix of both. There is also a specific version called post-infectious IBS. This occurs when the condition is triggered by an acute gastrointestinal infection, such as gastroenteritis. During these infections, the body may release proinflammatory cytokines, which are proteins that help manage inflammation. This can increase gut permeability, allowing bacteria to move across the epithelial barrier of the gut.

Medical history shows that humans have recognized these symptoms for a long time. The first formal description of the condition dates back to 1820. However, the specific name "irritable bowel syndrome" was not adopted until 1944. Since then, diagnostic criteria have evolved to help doctors identify the disorder more accurately. Modern doctors use the Rome IV diagnostic criteria to define the condition. This requires that symptoms have been present for at least six months. This history helps us see how much our understanding of digestive health has grown.

IBS is quite common across the entire planet. The average global prevalence is approximately 11.2%. However, this number varies greatly by region. For example, prevalence can range from 1.1% to 45.0% depending on the country and the specific diagnostic criteria used. It is notably more common in South America and less frequent in Southeast Asia. In Western nations, the condition is twice as common in women as it is in men. Most cases typically emerge before a person reaches age 45. Interestingly, the condition appears to become less common as people age.

Doctors must be careful to rule out other conditions before diagnosing IBS. They look for "alarm" features that might suggest a different problem. These include symptoms like unexplained weight loss, blood in the stool, or anemia. Other conditions that look similar to IBS include celiac disease, inflammatory bowel disease, and colon cancer. If a person develops symptoms after age 50, doctors will investigate more closely. Diagnosis is based on the presence of IBS symptoms in the absence of these more serious medical signs.

Managing IBS involves several different strategies to improve daily life. Many people find relief through dietary changes. One method is a low-FODMAP diet, which limits certain fermentable carbohydrates. This diet is intended for short-term or medium-term use rather than a lifelong restriction. Medications can also help manage specific symptoms. Loperamide is often used to treat diarrhea, while laxatives can help with constipation. Doctors may also prescribe antidepressants, such as tricyclic antidepressants like amitriptyline. Even without a mood disorder, these medications can help reduce abdominal pain.

Recent science is looking closely at the microbiota-gut-brain axis. This concept explores how the trillions of microbes in our gut influence our brain and our mood. Studies show that people with IBS often have dysbiosis, which is an imbalance in gut bacteria. For instance, some people show an increase in bacteria like Clostridia and a decrease in beneficial species like Lactobacillus. This microbial imbalance may contribute to both intestinal symptoms and psychiatric issues like anxiety or depression. Understanding this connection is a major focus for future medical research.